Montpied P, Weller M, Paul S M
Section on Molecular Pharmacology, National Institute of Mental Health, Bethesda, Maryland.
Biochem Biophys Res Commun. 1993 Sep 15;195(2):623-9. doi: 10.1006/bbrc.1993.2091.
The protooncogene bcl-2 was studied as a candidate gene for N-methyl-D-aspartate-(NMDA)-induced excitoprotection of cerebellar granule neurons. Exposure of these neurons to excitoprotective concentrations of NMDA and to excitotoxic concentrations of glutamate decreased bcl-2 mRNA levels. Preexposure to NMDA failed to modify the glutamate-evoked decrease in bcl-2 mRNA but increased neuronal survival from 20% to 100%. Neither the intracellular mechanisms underlying the cascade of excitoprotection induced by NMDA nor those underlying the cascade of glutamate toxicity of cerebellar granule neurons seem to specifically involve changes in bcl-2 mRNA levels. Glutamate did not induce nucleosomal DNA fragmentation but glutamate toxicity was inhibited by aurintricarboxylic acid. Glutamate toxicity of cerebellar granule neurons differs considerably from classical programmed cell death.
原癌基因bcl-2作为N-甲基-D-天冬氨酸(NMDA)诱导的小脑颗粒神经元兴奋性保护的候选基因进行了研究。将这些神经元暴露于兴奋性保护浓度的NMDA和兴奋性毒性浓度的谷氨酸盐中会降低bcl-2 mRNA水平。预先暴露于NMDA未能改变谷氨酸盐引起的bcl-2 mRNA下降,但可使神经元存活率从20%提高到100%。由NMDA诱导的兴奋性保护级联反应的细胞内机制以及小脑颗粒神经元谷氨酸毒性级联反应的细胞内机制似乎都不特别涉及bcl-2 mRNA水平的变化。谷氨酸盐未诱导核小体DNA片段化,但金精三羧酸可抑制谷氨酸盐毒性。小脑颗粒神经元的谷氨酸盐毒性与经典的程序性细胞死亡有很大不同。